Previous clinical reports show a higher level of Ang II in COVID‐19 patients, compared with healthy individuals,66 which is attributed to SARS‐CoV‐2 infection‐mediated ACE2 downregulation and is correlated with viral load and pulmonary injury.67, 68. The gene discussed is ACE2; the disease is COVID-19.